A group from Zhengzhou University discovered that miR-506 regulated the expression of Sp1 transcription factor (SP1) and Sp3 transcription factor (SP3), thereby reducing MEG3 methylation and inhibiting the migration and invasion of BC cells (Wang et al., 2018b). The gene discussed is MEG3; the disease is breast cancer.